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Equol, an isoflavonoid metabolite produced from the
dietary isoflavone daidzein by the gut microflora in
mammals, has been found to protect not only against
ultraviolet (UV) radiation-induced cutaneous inflammation
and photoimmune suppression, but also have anti-
photocarcinogenic properties in mice. Because the state of
DNA damage has been correlated with suppression of the
immune system and photocarcinogenesis, we have therefore
examined the potential of equol to offer protection from
solar-simulated UV (SSUV) radiation-induced DNA damage
in hairless mice by the immunohistochemical approach
using monoclonal antibody specific for cyclobutane
pyrimidine dimers (CPDs; H3 antibody). Topical application
of 20 µM equol lotion, which was applied both before and
after SSUV significantly reduced the number of CPDs.
This reduction was evident immediately after SSUV
exposure, at 1 h after exposure, and at 24 h after exposure,
revealing 54%, 50%, and 26% reduction in CPDs,
respectively. When the same concentration was applied
for 5 consecutive days after SSUV exposure, there was no
significant difference in the reduction of CPDs
immediately after SSUV irradiation or at 1 hour afterwards,
but there were significant reductions of 23% and 42% at
24 and 48 h after SSUV exposure, respectively. Despite
apparently reducing the number of CPDs post-SSUV,
topically applied equol did not appear to increase the rate
of dimer removal. To conclude, equol applied topically
prior to SSUV irradiation offers protection against CPD
formation in hairless mice, possibly by acting as a
suncreen and thus inhibiting DNA photodamage.
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Introduction
Ultraviolet (UV) irradiation, in particular the middle
wavelength range (UVB, 280-320 nm), has been clearly
shown to be the primary cause of non-melanoma skin
cancer [25]. Studies have indicated that UV irradiation
induces skin cancer primarily by its DNA-damaging
properties and also its capacity to suppress the immune
system. The mechanism of UV-induced immune suppression
is not completely understood. Evidence is accumulating,
however, that UVB-induced DNA damage represents a key
step in the initiation of immune suppression [2], although
other mechanisms, such as the photoisomerization of
urocanic acid [20], free radical formation [7], and signal
transduction-mediated activation of transcription factors
[8,23], may play a role as well. Following UV exposure,
DNA forms cyclobutane pyrimidine dimers (CPDs) and (6-
4) photoproducts [6]. UV irradiation-induced CPD formation,
in particular, leads to the release of immunosuppressive
cytokines, such as IL-10, from keratinocytes [19]. Furthermore,
in >90% of UV-induced human skin cancers, CPDs can be
localized within the cell cycle regulatory gene p53 [5,31],
which also acts as a tumor suppressor gene, suggesting a
significant role of UV-induced DNA damage in
photocarcinogenesis. Hence, UV irradiation-induced DNA
damage is the crucial event for suppression of the immune
system, which leads to skin cancer development.
Recent studies in mice with topically applied isoflavonoids
derived from the red clover, Trifolium pratense, have shown
that these phytochemicals may protect effectively against
UV radiation-induced skin damage. Particular interest has
centered on equol ([S]-4'7-dihydroxyisoflavane), an isoflavonoid
metabolite produced from the dietary isoflavone daidzein by
the gut microflora in mammals. Equol has been found to
protect not only against UV radiation-induced cutaneous
inflammation, observed as the sunburn reaction, but also
against photoimmune suppression, which is evident as a
defective contact hypersensitivity (CHS) reaction initiated
by the UV-irradiated skin [29]. The immunoprotective
mechanism of topically applied equol involves the inactivation
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of the downstream actions of cis-urocanic acid, a major UV-
induced immunosuppressive photoproduct produced in the
skin [29]. Photoimmune suppression is a prerequisite for the
promotion of UV radiation-initiated tumors, and topically
applied equol has been demonstrated to have anti-
photocarcinogenic properties in mice [28], thus the
photoprotective effects of equol offer the opportunity to
identify critical pathways linking the UV-induced immune
defect with the development of skin cancer. In addition,
equol has the capacity to stimulate the induction of
metallothionein (MT), which is one of the endogenous
cutaneous antioxidants that have been identified as relevant
for protection against oxidative photodamage [27].
Because the state of DNA damage has also been correlated
with suppression of the immune system and photocarcinogenesis,
it was of interest to study the possible DNA damage
protection effects of topical equol, when applied to the skin
before and after moderate short-term acute SSUV exposure.
We hypothesize that the observed anti-immunosuppressive
and anti-carcinogenic effects of topically applied equol
[28,29], are associated with equol’s protection of DNA
against damage following SSUV exposure. In this study, we
report the effect of topical application of equol to the skin of
the hairless mouse prior to, or immediately after, SSUV
exposure on the reduction and removal of CPDs by the
immunohistochemical staining method.
Materials and Methods
Animals
Age-matched inbred female hairless albino (Skh:HR-1)
mice aged 8-10 weeks were used in this study (Veterinary
Breeding Colony University of Sydney, Australia). They
were housed in wire-topped plastic boxes on compressed
paper bedding (Boral, Australia), and maintained at 25
oC
with 12 h light (GEC F40G0 gold light, which does not emit
any UV), alternating with 12 h dark. They were fed standard
laboratory mouse pellets (Norco Stockfeeds, Australia) and
tap water ad libitum. All procedures for using animals were
approved by the University of Sydney Animal Ethics
Committee and complied with the State Animal Research
Act 1985.
UV Irradiation
SSUV radiation was carried out as described previously
[29]. One group of mice was exposed to SSUV on the
dorsum, with the daily dose providing 0.167 J/cm
2, which is
approximately one minimum erythemal dose (1MED) for
this mouse each day, for three consecutive days (3 × 1
MED). The other group was exposed to a single SSUV dose
providing 0.501 J/cm
2 of UVB, which is approximately
equal to 3MED (1 × 3 MED of SSUV exposure).
Topical lotion
Equol was purchased from Sigma-Aldrich, Australia. The
compound was dissolved in DMSO, then diluted to the
required concentration in an innocuous oil-in-water cosmetic
lotion (base lotion) as described previously [28,29], without
color, perfume, or preservative, so that the final lotion
contained 20 mM of equol and 0.5% (vol/vol) DMSO.
Aliquots of 0.2 ml were applied to the dorsum of mice and
spread with a gloved finger; the mice were held on their
cage top while the lotion was absorbed into the skin.
Protocol of study
Two different protocols of treatment were conducted to
observe the effect of the SSUV exposure regime on the CPD
appearance and the time course of their removal. These
treatment groups were: (i) 3 × 1 MED and (ii) 1 × 3 MED of
SSUV exposure. No topical application of equol or base
lotion was used in this protocol. Three different protocols of
treatment were conducted to assess the effect of equol on the
reduction and removal of CPD following SSUV exposure.
These treatment groups were: 1 × 3 MED of SSUV exposure
plus equol, which was applied (i) immediately after SSUV
exposure for 5 days; (ii) for 7 days prior to SSUV exposure
and then continued for 5 days immediately after SSUV
exposure and (iii) 1 × 3 MED of SSUV exposure plus base
lotion, which was applied immediately after SSUV exposure
for 5 days.
Immunohistochemical staining for the detection of
CPDs
The immunonostaining procedure for CPD detection was
carried out as previously described [22] with a slight
modification. The H3 antibody, a monoclonal antibody
specific for cyclobutane thymine dimers, was purchased
from TNO Nutrition and Food Research (Netherlands).
Collection of skin samples: Two mice from each treatment
group were killed 30 min after 1 × 3 MED and 3 × 1 MED
of SSUV exposure and at 1, 24, 48, 72 and 168 h after
exposure. Mid-dorsal skins of mice were excised, fixed in
Histochoice (Amresco, USA) for 4 h, processed overnight
with a formalin-based automated methodology, and paraffin-
embedded. Subsequently, tissue sections were cut at 5 mm
onto poly-l-lysine coated slides (Sigma-Aldrich, Australia).
Immunohistochemical staining: The tissue sections were
deparaffinized through xylol and graded ethanol solutions to
70%. Endogenous peroxidase was quenched by incubation
in 0.3% (vol/vol) hydrogen peroxide (Riedel-deHaen, Germany)
in methanol. Citric acid buffer (pH 6.0) and microwave
treatment were used for antigen retrieval. To denature DNA
in situ, tissue sections were then incubated in 50% ethanol
for 5 min, 0.02 N HCl in 30% ethanol for 2 min, 0.05 N HCl
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70% ethanol, and then treated with 30 µg proteinase K in
1 ml Tris calcium chloride (Sigma, USA), at 37
oC for 10
min. To absorb non-specific mouse tissue reactivity, the
tissue sections were incubated in specific mouse IgG (1 : 25
dilution) (MOM kit; Vector, USA) prior to incubation with
the H3 antibody.
H3 antibody was applied onto each tissue section (1 : 75
dilution) and incubated overnight at 4
oC. Subsequently, the
tissue sections were incubated at room temperature for 40
min with biotinylated anti-mouse IgG (1 : 250 dilution;
Vector, USA). Finally, the immunoreactions were visualized
using avidin-biotin peroxidase complexes (Vectastain ABC
kit; Vector, USA), and the peroxidase reaction was developed
in 3,3'-diaminobenzidine chromogen (Dako, USA). Tissue
sections were counterstained with haematoxylin, followed
by dehydration through graded ethanol solutions to 100%,
and then mounted in DPX. Non-immune mouse serum in
PBS containing 10% FCS was used as an isotype control
(Mouse IgG; ICN Biomedicals, Australia).
Analysis of the presence of CPDs: The number of positive
staining cells was counted using a program in a Leica Q500
MC image processing and analysis system (Leica Microsystem,
Switzerland). Positively stained CPDs (brown color) were
identified on the displayed image and also recorded
photographically with the Adobe Photoshop program
(Adobe Photoshop 5.5). Excessive boiling in citric acid
buffer severely damaged the dermal cutaneous compartment.
Therefore, only the number of thymine dimers in the
epidermal layer of the skin were counted. A minimum of 20
randomly selected fields per section from each mouse were
analyzed.
Statistical analysis
Statistical analysis was performed with ANOVA and
followed by the Student’s t test for significance (Microsoft
Excel, USA). All data were expressed as mean ± SE, for
each time point of each treatment group.
Results
Under our experimental conditions, in which SSUV was
used as a source of radiation, positively stained CPDs were
found in the nuclei and in the cytoplasm of epidermal and
dermal layers of the skin. Only those CPDs observed in the
epidermal cutaneous compartment were selected for the
study detailed in this paper.
Effect of the UV exposure regime on the CPD appearance
and the time course of their removal Fig. 1 shows that the
peak of CPD appearance occurred at 1 hour after a single
dose of 3 MED SSUV exposure (1 × 3 MED of SSUV
exposure). Subsequently, at 24 and 48 h post-SSUV exposure,
there was apparent removal of CPDs, down to 47% and 79%
respectively (p< 0.01 and p< 0.001 respectively). These
dimers then completely disappeared from the epidermal
cells by 168 h after irradiation. In contrast, when 3 irradiations
with 1 MED of SSUV daily (3 ×1 MED of SSUV exposure)
was applied, the peak of CPD appearance was established at
48 h following the first SSUV exposure (p< 0.05). Subsequently,
by 72 h post-SSUV irradiation, the appearance of these
dimers markedly decreased (p < 0.01), revealing 42%
removal of CPDs. In this model of radiation, the CPD
response after the first exposure to 1 MED was significantly
less than after 3 MED of SSUV (p < 0.01). Moreover, the
Fig. 1. Accumulation of cyclobutane pyrimidine dimers (CPDs) upon repeated irradiation, or following a single dose of irradiation wit h
solar-simulated ultraviolet radiation (SSUV), expressed as the average number CPD (mean ± SE). Mice were irradiated daily wit h
1.16 kJ/m
2 UVB and 18.52 kJ/m
2 UVA for three consecutive days (3 × 1 MED of SSUV), or a single dose of 3.48 kJ/m
2 UVB and 55.6
kJ/m
2 UVA (1 × 3 MED of SSUV), or not irradiated. Mice were killed at 0 (non-SSUV irradiated skin), 1, 24, 48, 72, and 168 h afte r
being exposed to SSUV. 3 MED SSUV single dose vs 1 MED for 3 days at 1 and 48 h post SSUV irradiation was not significan t
(p > 0.05). Skin samples were taken from 2 mice at each time point.220 Sitarina Widyarini
CPDs induced by subsequent SSUV had an additive effect,
and after the third SSUV exposure resulted in approximately
the same number of dimers as after 1 × 3 MED of SSUV
exposure. These CPDs were mostly removed, but some
remained present at 168 h.
Effect of equol on the reduction and the removal of
CPDs following SSUV exposure
Topical application of 20 mM equol lotion was observed
to protect against SSUV-induced CPDs, when it was applied
for 7 days prior to SSUV exposure and 5 days following (b/
a) SSUV exposure (Fig. 2). Equol that was applied both
before and after SSUV significantly reduced the number of
CPDs. This reduction was evident immediately after SSUV
exposure and at 1 and 24 h afterwards (p < 0.01; revealing
54%, 50%, and 26% reduction of CPDs respectively),
compared to the control group (SSUV only) at the same
time points, and was still significant at 48 h post-SSUV
irradiation (p < 0.05). By 72 h after SSUV exposure, there
was no significant difference in the number of CPDs in the
control group, or the groups treated with equol (p > 0.05).
These dimers had completely disappeared from the
epidermal cells by 168 h after irradiation in all groups
(p > 0.05).  On the other hand, when 20 mM equol was
applied for 5 consecutive days after SSUV exposure (a),
there was no significant difference in the number of CPDs
immediately after SSUV irradiation, or at 1 h afterwards,
compared to the control group (p > 0.05), even though it
appears that there were fewer CPDs (Fig. 2). As the dimers
were removed at 24 and 48 h after SSUV exposure, the
number remained less than in the control group, revealing a
significant reduction of 23% and 42% in CPDs, respectively
(p < 0.05). By 72 h after SSUV exposure there was no
significant difference in the number of CPDs. However, the
rate of CPD removal in the equol-treated mice was not
different from the rate in control mice. Thus, equol protected
significantly from CPD formation only if applied prior to
SSUV exposure.
The removal of CPDs following a single dose of 3 MED
SSUV (1 ×3 MED of SSUV exposure) is shown histologically
in Fig. 3 (a-h). Chronologically, immediately after and at 1 h
after SSUV exposure, most of the CPDs were found in the
basal layer of the epidermis. By 24 and 48 h post-SSUV
irradiation, CPDs were found in the upper layer of the
epidermis and only a few were detected in the basal layer of
the epidermis. Subsequently, at 72 h post-SSUV exposure,
CPDs were found in the keratinocyte layer, but had completely
disappeared by 7 days post-SSUV irradiation. UV-induced
CPD formation increases the chance of inheritable changes
in p53 genes. This chance is greater in tissues with
proliferating cells than in tissues with resting cells [5,31].
These findings support our results, demonstrating that CPDs
were initially found in the basal layer of the epidermis, in
which the cells are normally actively proliferating.
Fig. 2. Effect of topical 20 µM equol lotion on the removal of cyclobutane pyrimidine dimers (CPDs) after irradiation with solar-
simulated ultraviolet radiation (SSUV), expressed as the average number CPD (mean ± SE). Mice were irradiated with a single dose  of
3.48 kJ/m
2 UVB and 55.6 kJ/m
2 UVA (1 × 3 MED of SSUV), or not irradiated, and then killed immediately (0.5 h post-SSUV exposure)
and at 1, 24, 48, 72, and 168 h post-SSUV exposure. Skin samples were taken from 2 mice at each time point. *: Equol was applied  for
7 days prior to SSUV and was continued for 5 consecutive days immediately after SSUV exposure. 
†: Equol was applied immediately
after SSUV exposure for 5 consecutive days. SSUV + BL vs SSUV + 20  µM equol 
† at 0.5 and 1 h post-SSUV irradiation was not
significant (p >0 . 0 5 ) .Isoflavone equol and UV-induced skin DNA damage 221
Discussion
Exposure to ultraviolet B radiation (UVB), demonstrated
to be the main waveband that is responsible for both UV-
induced immunosuppression [15] and photocarcinogenesis
[13], results mainly in the production of CPDs and (6-4)
photoproducts. These comprise about 95% of the UVB-
induced DNA lesions [10], seem to be pre-mutagenic in
mammalian cells [4], and play a crucial role in both
photocarcinogenesis and photoimmunosuppression [5,14].
Under our experimental conditions, CPDs were found
intracellularly, both in epidermal and dermal cells following
SSUV irradiation. This finding was consistent with a previous
immunofluorescence staining study that demonstrated that,
following UVB exposure (8 J/m
2), CPDs were present in
both the nuclei and cytoplasm of the dermal and epidermal
cells [24]. We observed that the peak of CPD appearance
and the time course of their removal depended on the UV
exposure regime. The peak of CPD appearance was within
1 h after 1 ×3 MED of SSUV exposure. Repeated irradiation
(3 × 1 MED of SSUV exposure) resulted in the peak of CPD
appearance at 48 h after the first SSUV exposure. However,
there were fewer CPDs at 1 h after the first 3 × 1 MED of
SSUV exposure than after 1 × 3 MED of SSUV irradiation,
indicating a UV dose responsiveness. A linear dose-dependent
induction of CPDs in hairless mouse epidermis following
UVB irradiation has been demonstrated in a previous study
[26]. Following 1 × 3 MED of SSUV exposure, there was
apparent removal of CPDs (approximately 47%) at 24 h and
they completely disappeared from the epidermal cells by
168 h after irradiation, consistent with previously described
studies [21,26]. In contrast, after repeated SSUV exposure,
there was obvious removal of CPDs (approximately 42%)
after 72 h, which was 24 h after the final irradiation, but
some remained for up to 168 h after SSUV exposure. Thus,
this finding indicates that following repeated irradiation, the
removal rate of CPDs is slower than after a single dose of
UV exposure. This retardation of CPD repair may be due to
the effects of UV on DNA repair enzymes, e.g. nucleotide
excision repair, as described in an in vitro study [12].
By using a single dose of SSUV (1 × 3 MED of SSUV
exposure), we found that equol, applied before SSUV
exposure, protected against SSUV-induced DNA damage by
reducing the number of CPDs substantially at 0.5 h and
significantly at 24-48 h. This finding suggests that equol
may act as a mild UVB sunscreen, since it has a UV
absorption peak in the UVB waveband at 281 nm [9]. Our
unpublished data also demonstrated that repeated applications
of equol caused residual equol to accumulate in the skin and
provided a mild sunscreening effect against exposure of
SSUV administered 24 h later. Mouse studies have shown
that sunscreens can inhibit DNA photodamage [16,30] and
p53 mutation [1]. Moreover, since dimer formation is
important in erythema [17], and sensitivity to erythema/
edema in mice has been associated with the inability to carry
out transcription-coupled repair of thymine dimer lesions
[3], we suggest that the mild sunscreening effect of residual
equol during chronic application may have endowed
protection from UV-induced skin inflammation in mice
(erythema-associated oedema) [29], mediated via reduced
CPD formation. Moreover, some slight evidence suggested
that topically applied equol after SSUV exposure might
encourage CPD removal at 24-48 h. Despite apparently
reducing the number of CPDs, equol applied topically post-
SSUV irradiation did not appear to increase the rate of dimer
Fig. 3. The time course of the removal of cyclobutane pyrimidine
dimers (CPDs) following a single dose of 3 MED of solar-
simulated ultraviolet radiation (SSUV). All sections were staine d
using ABC methods. ×200. A; Normal mouse skin (non-SSUV-
irradiated). B; Isotype control of CPD staining, immediately afte r
SSUV exposure. C; The appearance of CPDs immediately afte r
SSUV exposure. Most of CPDs were distributed in the basal
layer of epidermis. D; The appearance of CPDs 1 h post-SSUV
exposure. Most of CPDs were distributed in the basal layer o f
epidermis. E; The appearance of CPDs 24 h post-SSUV exposure.
Most of CPDs were found in the upper layer of epidermis with  a
few CPDs remaining in the basal layer of epidermis. F; The
appearance of CPDs 48 h post-SSUV exposure. Most of CPDs
were found in the upper layer of epidermis, and only a few CPDs
were found in the basal layer of epidermis. G; The appearance o f
CPDs 72 h post-SSUV exposure. CPDs were found in the
keratinocyte layer. H; 168 h post-SSUV exposure, CPDs ha d
completely disappeared from the epidermal layer.222 Sitarina Widyarini
removal at other time points (0.5-168 h). However, our
results need substantiating in the future, perhaps by using
more sensitive techniques for CPD quantitation, such as
flow cytometry or alkaline gel electrophoresis.
Transformation of urocanic acid (UCA) from its trans to
its cis isomer in the stratum corneum has been shown to
exhibit properties of immunosuppression [11]. Moreover,
there is also evidence that UCA may be involved in DNA
damage through its ability to photosensitize the formation of
pyrimidine dimers in vitro [18]. This indicates that the DNA
and UCA-mediated photoimmunosuppression effects might
be linked. We established that the immunoprotective properties
of equol against acute UV exposure were achieved by
inactivation of cis-UCA [29]. Therefore, we speculate that
inactivation of cis-UCA by equol might impede UCA’s
ability to photosensitize the formation of CPDs, partially
accounting for the reduced number of CPDs formed in
SSUV-irradiated mice treated with equol.
In conclusion, the results of this study have shown that,
whereas topical application of equol provided significant
protection against formation of CPDs when it was applied
prior to SSUV exposure, application of equol following
SSUV irradiation did not result in significant reduction in
CPD formation. This study also suggested that equol present
on the skin prior to SSUV irradiation can contribute to the
protection we report against SSUV-induced erythema-
associated oedema, immunosuppression [29], and skin
cancer [28], by acting as a sunscreen and thus inhibiting
DNA photodamage.
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